FDA inspection
Maxigen Biotech, Inc.: FDA inspection ending May 21, 2015
FDA inspection 930565 · Voluntary Action Indicated (VAI) · Taoyuan City
Key facts
| Inspection ID | 930565 |
|---|---|
| Firm | Maxigen Biotech, Inc. |
| FEI number | 3004146122 |
| Address | Guishan District, No. 88 Keji 1st Rd.; Guishan Dist. |
| City | Taoyuan City |
| Country | Taiwan |
| Fiscal year | 2015 |
| Inspection end date | May 21, 2015 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data